8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
An expert overview of the literature, useful as background reading.
2015 / Narrative review
This article reviews the role of early-life protein intake on metabolic programming, specifically focusing on the early protein hypothesis. Observational studies and clinical trials demonstrate that reducing the protein content in infant and follow-on formulas may lower later obesity risk. Mechanistic pathways may involve branched-chain amino acids, insulin, and insulin-like growth factor 1 via mTOR. Identified research gaps include the critical window for programming adiposity and the long-term consequences of protein intake differences on organ functionality.
Luque V, Closa-Monasterolo R, Escribano J, et al. Nutr Metab Insights, 2015. PMID 27013888
2015 / Critical review
This review examines the use of body mass index (BMI) for defining anthropometric characteristics, categorizing fatness, assessing disease risk, and informing public health policy. Although useful in population-based research, BMI is a poor indicator of body fat percentage and fails to capture the mass of fat across different body sites. Furthermore, evidence shows a wide range of BMIs over which mortality risk is modest, an effect that is age related.
Nuttall FQ Nutr Today, 2015. PMID 27340299
2014 / Narrative review
This review examined the potential role of dark chocolate and cocoa polyphenols in managing obesity. Evidence from animal models, cell cultures, and a small number of human observational and clinical trials indicates promising effects. Suggested mechanisms include decreasing the expression of genes involved in fatty acid synthesis, reducing the digestion and absorption of fats and carbohydrates, and increasing satiety.
Farhat G, Drummond S, Fyfe L, et al. Phytother Res, 2014. PMID 24000103
2014 / Narrative review
This review examines the genetic epidemiology and biology of the fat mass and obesity associated (FTO) gene. FTO minor alleles increase BMI by 0.39 kg/m² (1,130 g in body weight) and obesity risk by 1.20-fold, with effects observed across diverse ancestries and age groups. Although FTO SNPs do not influence physical activity levels, physical activity attenuates FTO's effect on obesity susceptibility by approximately 30%. Evidence suggests FTO increases obesity risk by subtly changing food intake and preference, with emerging roles in nutrient sensing and mRNA translation.
Shows an association, not proof of cause and effect.
Loos RJ, Yeo GS Nat Rev Endocrinol, 2014. PMID 24247219
2014 / Narrative review of epidemiological evidence
This review examines the epidemiological evidence linking environmental pollutants, specifically persistent organic pollutants (POPs), to the development of diabetes. The authors note that while lifestyle factors such as poor diet and low physical activity are often cited, evidence linking them to the rapid increase in diabetes and obesity is considered poor. The paper summarizes and appraises current epidemiological studies relating POPs to diabetes while highlighting existing gaps and flaws in the literature.
Shows an association, not proof of cause and effect.
Magliano DJ, Loh VHY, Harding JL, et al. Diabetes Metab, 2014. PMID 24262435
2014 / Narrative review
This review evaluates the role of weight loss and macronutrient composition, specifically dietary fats and carbohydrates, in treating nonalcoholic fatty liver disease (NAFLD). Lifestyle modifications such as weight loss and exercise are primary clinical approaches, yet certain weight-loss regimens, such as very low carbohydrate, high fat diets, can exacerbate NAFLD and induce insulin resistance. Furthermore, macronutrient composition can alter NAFLD independent of weight change, with diets high in saturated fatty acids or refined carbohydrates exacerbating the condition.
Asrih M, Jornayvaz FR Clin Nutr, 2014. PMID 24262589
2014 / Narrative review
This review highlights recent advances in protein and nutrition research aimed at improving health outcomes in aging adults. Evidence supports moderately increasing protein consumption beyond the current Recommended Dietary Allowance using a meal-based approach. Findings from research on muscle protein anabolism, appetite regulation, and satiety suggest that meeting a threshold of approximately 30 g of protein per meal is a promising strategy for maintaining muscle mass while controlling body fat.
Paddon-Jones D, Leidy H Curr Opin Clin Nutr Metab Care, 2014. PMID 24310053
2014 / Narrative review
This review examined the role of caloric restriction and traditional foods with potential caloric restriction-mimetic properties in the healthy aging of Okinawans. Nutritional data support mild caloric restriction of 10-15% and high intake of foods like sweet potatoes, marine-based carotenoid-rich foods, and turmeric. Phenotypic evidence is consistent with caloric restriction, less age-related chronic disease (including cardiovascular diseases, cancer, and dementia), and longer lifespan. More research is needed to identify possible nutritional interventions for healthy aging.
Shows an association, not proof of cause and effect.
Willcox BJ, Willcox DC Curr Opin Clin Nutr Metab Care, 2014. PMID 24316687
2014 / Position paper / narrative review
The Academy of Nutrition and Dietetics released a position paper regarding dietary fatty acid intake for healthy adults. It recommends that dietary fat provide 20% to 35% of energy, emphasizing increased consumption of n-3 polyunsaturated fatty acids and limited intake of saturated and trans fats. A food-based approach is recommended, highlighting regular consumption of fatty fish, nuts, seeds, lean meats, low-fat dairy, vegetables, fruits, whole grains, and legumes.
NANO counterpoint →
Vannice G, Rasmussen H J Acad Nutr Diet, 2014. PMID 24342605
2014 / Narrative review
This review evaluated the current evidence on the relationship between sugar consumption and the development of retinal and eye conditions such as diabetic retinopathy, hypertensive retinopathy, age-related macular degeneration, non-arteritic anterior ischaemic optic neuropathy, and cataract. The authors note that sugar intake has risen five-fold over the past century, driven by sucrose and high-fructose corn syrup in processed foods and soft drinks. Furthermore, the review explores how refined carbohydrates and chronic hyperglycemia impact eye microvascular disease and retinal circulation.
Shows an association, not proof of cause and effect.
Kearney FM, Fagan XJ, Al-Qureshi S Clin Exp Ophthalmol, 2014. PMID 24373051
2014 / Narrative review
Bisphenol-A (BPA) is one of the highest volume chemicals produced worldwide, with over 6 billion pounds produced and over 100 t released into the atmosphere annually. Recent literature has raised concerns regarding BPA's possible implication in the etiology of human chronic diseases, including diabetes, obesity, reproductive disorders, cardiovascular diseases, birth defects, chronic respiratory and kidney diseases, and breast cancer. This review presents evidence on the relationship between BPA exposure and chronic diseases, discussing genetic, epigenetic, and endocrine disruption mechanisms, as well as oxidative stress, mitochondrial dysfunction, and cell signaling.
Shows an association, not proof of cause and effect.
Rezg R, El-Fazaa S, Gharbi N, et al. Environ Int, 2014. PMID 24382480
2014 / Narrative review
This review discusses the concept of normal weight obesity, defined as having a normal body weight by BMI alongside a high body fat percentage. Individuals with normal weight obesity exhibit metabolic dysregulation and are associated with a significantly higher risk of developing metabolic syndrome, cardiometabolic dysfunction, and higher mortality. In patients with coronary artery disease, normal BMI combined with central obesity was linked to the highest mortality risk compared to other adiposity patterns.
Shows an association, not proof of cause and effect.
Oliveros E, Somers VK, Sochor O, et al. Prog Cardiovasc Dis, 2014. PMID 24438734
2014 / Review
This review summarizes molecular mechanisms and clinical applications of fasting across organisms. In lower eukaryotes, chronic fasting extends longevity by reprogramming metabolic and stress resistance pathways, while intermittent or periodic fasting protects rodents against diabetes, cancers, heart disease, and neurodegeneration. In humans, fasting helps reduce obesity, hypertension, asthma, and rheumatoid arthritis. Fasting shows potential to delay aging and help prevent and treat disease while minimizing side effects associated with chronic dietary interventions.
Longo VD, Mattson MP Cell Metab, 2014. PMID 24440038
2014 / Narrative review
Recent studies link energy regulation to the circadian clock, showing that food intake timing may significantly affect obesity. A longitudinal study demonstrated that main meal timing predicted weight loss during a 20-week dietary intervention independently of total 24-hour caloric intake. Additionally, a 12-week experimental study showed that participants assigned to high caloric intake at breakfast lost significantly more weight than those assigned to high caloric intake at dinner. Active circadian clocks exist in organs related to food intake, and temporal patterns in adipose tissue genes appear crucial for regulating fat accumulation versus fat mobilization.
Garaulet M, Gómez-Abellán P Physiol Behav, 2014. PMID 24467926
2014 / Narrative review
This review summarizes evidence connecting gut microbiome activities with cardiovascular disease (CVD) and dietary modulation. Aberrant gut microbiota profiles are linked to obesity, diabetes, and non-alcoholic fatty liver disease, while microbial metabolites from choline, phosphatidylcholine, and l-carnitine directly contribute to CVD pathology. In human studies, selected bile-salt hydrolysing probiotic strains lowered blood cholesterol, and fermentable fibers and plant polyphenols appear to regulate microbial activities. The review concludes that dietary strategies modulating gut microbiota are emerging as efficacious tools for reducing CVD risk, suggesting the way to a healthy heart may be through a healthy gut.
Tuohy KM, Fava F, Viola R Proc Nutr Soc, 2014. PMID 24495527
2014 / Narrative review
This review summarizes the epidemiology, complications, healthcare costs, and risk factors of gastroesophageal reflux disease (GERD). The prevalence of GERD symptoms rose approximately 50% until the mid-1990s before plateauing, alongside shifting trends in complications like esophageal adenocarcinoma and strictures. Reported risk factors for GERD include obesity, poor diet, lack of physical activity, consumption of tobacco and alcohol, and respiratory diseases.
Shows an association, not proof of cause and effect.
Rubenstein JH, Chen JW Gastroenterol Clin North Am, 2014. PMID 24503355
2014 / Narrative review / commentary
In 2012, the FDA approved lorcaserin and phentermine-topiramate based on 1-year trials alongside recommendations for a calorie-restricted diet and exercise. Patients lost more weight than those on placebo: 3% (95% CI, 3%-4%) more with lorcaserin and 7% (95% CI, 3%-4%) more with phentermine/topiramate. However, both drugs carry warnings for memory, attention, or language problems and depression, alongside other serious drug-specific harms. Neither drug is marketed in Europe due to safety concerns, and required postmarketing safety trials in the US are behind schedule.
Woloshin S, Schwartz LM JAMA Intern Med, 2014. PMID 24515599
2014 / Narrative review
This review examines the role of intestinal microbiota and fecal transplantation in insulin resistance and type 2 diabetes mellitus. Alterations in intestinal microbiota composition promote systemic inflammation, which is a hallmark of obesity and subsequent insulin resistance. Fecal transplantation studies indicate that butyrate-producing intestinal bacteria are crucial key players in regulating diverse signaling cascades linked to human glucose and lipid metabolism.
Udayappan SD, Hartstra AV, Dallinga-Thie GM, et al. Clin Exp Immunol, 2014. PMID 24528224
2014 / Narrative review
This review discusses the influence of diet, gut microbiota, and inflammation on type 2 diabetes mellitus (T2DM). High-fat diets can promote dysbiosis and inflammation, whereas prebiotics may reduce inflammation, improve insulin resistance, and regulate appetite hormones. A recent 21-day intervention study in T2DM patients reported that the macrobiotic Ma-Pi 2 diet significantly improved fasting blood glucose, plasma lipid fractions, plasma insulin, and homeostasis. The authors note that these effects must be confirmed in larger randomized controlled trials evaluating indicators of inflammation.
Fallucca F, Porrata C, Fallucca S, et al. Diabetes Metab Res Rev, 2014. PMID 24532292
2014 / Narrative review
This review summarizes hidradenitis suppurativa (HS), a chronic, relapsing, inflammatory skin condition typically occurring after puberty with an estimated worldwide prevalence of 1-4%. It is three times more common in women than men and presents as painful inflamed nodules progressing to abscesses and scarring. Recognized risk factors for HS include smoking and obesity, and comorbidities include inflammatory bowel disease and spondyloarthropathies.
Shows an association, not proof of cause and effect.
Dufour DN, Emtestam L, Jemec GB Postgrad Med J, 2014. PMID 24567417
2014 / Narrative review
This review discusses the interactions between diet, gut microbiota, and host immune functions in relation to metabolic disorders. The gut microbial composition changes dynamically in response to factors such as host genetics, age, and environment. Dietary regulation affects microbial metabolism and host immunity via mechanisms including nutrient fermentation, intestinal barrier function, gene expression, and immune responses. Modulating gut microbiota through diet patterns, probiotics, prebiotics, and antibiotics shows potential for preventing obesity.
Chen J, He X, Huang J J Food Sci, 2014. PMID 24621052
2014 / Narrative review
This review evaluates basic, clinical, and population research regarding optimal body weight. Epidemiological studies show strong direct associations between increasing BMI and risks of developing type 2 diabetes, cardiovascular disease, and several cancers, beginning from a BMI of 20-21 kg m(-2). Although a recent meta-analysis suggested overweight individuals have lower overall mortality than normal-weight individuals, the authors note this is likely an artifact of methodological issues including smoking confounding, reverse causation, and loss of lean mass in frail elderly individuals.
Shows an association, not proof of cause and effect.
Fontana L, Hu FB Aging Cell, 2014. PMID 24628815
2014 / Narrative review
This review details how obesity and related metabolic conditions contribute to hepatocarcinogenesis. Obesity-associated hepatocellular carcinoma is attributed to chronic inflammation from adipose remodeling, pro-inflammatory adipokine secretion, ectopic lipid accumulation, altered gut microbiota, disrupted stellate cell senescence, and insulin resistance with elevated insulin and insulin-like growth factors. These pathways synergize with chronic liver disease from other etiologies to accelerate hepatocellular carcinoma development.
Shows an association, not proof of cause and effect.
Karagozian R, Derdák Z, Baffy G Metabolism, 2014. PMID 24629562
2014 / Narrative review
This narrative review examined data on dietary sugar consumption and related health risks, including NHANES, USDA surveys, meta-analyses, and randomized controlled trials. About 75% of foods and beverages contain added sugar, and soft drink consumption has increased fivefold since 1950. Meta-analyses indicate sugar-sweetened beverage (SSB) intake is related to risks of diabetes, metabolic syndrome, and cardiovascular disease, and drinking two 16-ounce SSBs daily for 6 months induced metabolic syndrome features and fatty liver. Trials lasting 6 months to 2 years showed that lowering soft drink intake reduced weight gain.
Bray GA, Popkin BM Diabetes Care, 2014. PMID 24652725